These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes. Mukherjee R, Wagar D, Stephens TA, Lee-Chan E, Singh B. J Immunol; 2005 May 01; 174(9):5306-15. PubMed ID: 15843527 [Abstract] [Full Text] [Related]
7. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes. Serreze DV, Marron MP, Dilorenzo TP. Ann N Y Acad Sci; 2007 Apr 01; 1103():103-11. PubMed ID: 17376821 [Abstract] [Full Text] [Related]
8. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Pang S, Zhang L, Wang H, Yi Z, Li L, Gao L, Zhao J, Tisch R, Katz JD, Wang B. Eur J Immunol; 2009 Oct 01; 39(10):2716-24. PubMed ID: 19658094 [Abstract] [Full Text] [Related]
12. Autoantigen recognition is required for recruitment of IGRP(206-214)-autoreactive CD8+ T cells but is dispensable for tolerance. Wang J, Tsai S, Han B, Tailor P, Santamaria P. J Immunol; 2012 Sep 15; 189(6):2975-84. PubMed ID: 22908330 [Abstract] [Full Text] [Related]
13. Genetic and therapeutic control of diabetogenic CD8+ T cells. Santamaria P. Novartis Found Symp; 2008 Sep 15; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463 [Abstract] [Full Text] [Related]
15. Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo. Wang Y, Flemming BP, Martin CC, Allen SR, Walters J, Oeser JK, Hutton JC, O'Brien RM. Diabetes; 2008 Jan 15; 57(1):133-41. PubMed ID: 17942825 [Abstract] [Full Text] [Related]
16. Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma. Zwicker K, Chatten C, Gratton K, Demetrick D, Serra P, Shameli A, Santamaria P, Bathe OF. J Immunol; 2009 Aug 01; 183(3):1705-14. PubMed ID: 19570832 [Abstract] [Full Text] [Related]
17. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Han B, Serra P, Amrani A, Yamanouchi J, Marée AF, Edelstein-Keshet L, Santamaria P. Nat Med; 2005 Jun 01; 11(6):645-52. PubMed ID: 15908957 [Abstract] [Full Text] [Related]
18. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. Li L, He Q, Garland A, Yi Z, Aybar LT, Kepler TB, Frelinger JA, Wang B, Tisch R. J Immunol; 2009 Dec 01; 183(11):7585-91. PubMed ID: 19917704 [Abstract] [Full Text] [Related]
19. A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Hutton JC, Eisenbarth GS. Proc Natl Acad Sci U S A; 2003 Jul 22; 100(15):8626-8. PubMed ID: 12861077 [No Abstract] [Full Text] [Related]
20. Adult-onset type 1 diabetes patients display decreased IGRP-specific Tr1 cells in blood. Chujo D, Nguyen TS, Foucat E, Blankenship D, Banchereau J, Nepom GT, Chaussabel D, Ueno H. Clin Immunol; 2015 Dec 22; 161(2):270-7. PubMed ID: 26341315 [Abstract] [Full Text] [Related] Page: [Next] [New Search]